
Aug 28, 2025, 18:29
Lung Breakthroughs at ESTRO25
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn:
“Lung breakthroughs at ESTRO25!
From osimertinib after chemoradiation in unresectable EGFR-mutant NSCLC (LAURA trial) to SBRT dose precision and ctDNA insights post-SABR, the lung sessions delivered key updates on optimising treatment and tracking response.
Read the summary of selected lung sessions, featuring highlights from the proffered papers and poster discussions.”
More posts featuring ESTRO.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 28, 2025, 18:29
Aug 28, 2025, 18:28
Aug 28, 2025, 18:24
Aug 28, 2025, 18:20
Aug 28, 2025, 18:05
Aug 28, 2025, 17:59
Aug 28, 2025, 17:54
Aug 28, 2025, 17:54
Aug 28, 2025, 17:47